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Three-dimensional ﬂuorescence spectroscopyAlzheimer's disease is characterized by the presence of extracellular deposits of amyloid, primarily composed of
the amyloid β-protein (Aβ). A growing body of evidence indicates that oligomeric forms of Aβ play a critical role
in disease causation. Soybean isoﬂavones are ﬂavonoids with an isoﬂavone backbone. Isoﬂavones have been
reported to protect against Aβ-induced neurotoxicity in cultured cell systems, the molecular mechanisms re-
main unclear. Our previous studies demonstrated that red wine-related ﬂavonoids with a ﬂavone backbone
are able to inhibit Aβ assembly and destabilize preformed Aβ aggregates. Here, we show that isoﬂavones, espe-
cially glycitein and genistein, have anti-ﬁbrillization, anti-oligomerization and ﬁbril-destabilizing effects on
Aβ1–40 and Aβ1–42 in vitro at physiological pH and temperature, by using nucleation-dependent polymerization
monitored by thioﬂavin T ﬂuorescence, atomic force microscopy, electron microscopy, and photo-induced
cross-linking of unmodiﬁed proteins followed by SDS-PAGE. Our three-dimensional ﬂuorescence spectroscopic
analyses demonstrated that glycitein interacted with Aβ monomers, oligomers and ﬁbrils, indicating speciﬁc
binding of glycitein to these Aβ species. Glycitein also interacted with different Aβ fragments (Aβ1–42, Aβ1–40,
Aβ1–16 and Aβ25–35), exhibiting the highest ﬂuorescence enhancement with Aβ25–35. We speculated that
glycitein's anti-amyloidogenic properties are speciﬁcally mediated by its binding to Aβ monomers, oligomers
and ﬁbrils. Isoﬂavones may hold promise as a treatment option for preventative strategies targeting amyloid
formation in Alzheimer's disease.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Alzheimer's disease is characterized by the presence of intracellu-
lar neuroﬁbrillary tangles consisting of hyperphosphorylated tau and
extracellular parenchymal and vascular amyloid deposits largely com-
posed of amyloid β-protein (Aβ) [1]. The aggregation of Aβmonomers
and β-sheet formation are considered to be critical events rendering
these peptides neurotoxic [2]. Moreover, oligomeric forms of Aβ
appear to play a crucial role in disease causation [3–7].
Flavonoids are chemically classiﬁed into a number of different
groups; i.e., ﬂavone, ﬂavonol, ﬂavanone, ﬂavan-3-ol, anthocyanidin
and isoﬂavone (Supplemental Fig. S1A). A substantial body of evidence
indicates that ﬂavonoids can inhibit the ﬁbrillization of a variety of
amyloidogenic proteins [8–10]. Isoﬂavones are a chemical class withorce microscopy; AU, arbitrary
i, daidzein; DTT, dithiothreitol;
n; EX, excitation; fAβs, Aβ ﬁ-
; PB, phosphate buffer; PICUP,
Pur, purunetin; SE, standard
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l rights reserved.about 15 members, and are found in high concentrations in soybean,
red clover, Puerariamiriﬁca and other plants. Stilbenoids are polypheno-
lic compounds derived from natural products. Resveratrol is a major
stilbenoid (Supplemental Fig. S1B), which has been reported to exert
potent neuroprotective effects [11]. Although epidemiological studies
on oral consumption of isoﬂavones for Alzheimer's disease have never
been reported, the consumption of red wine, related to resveratrol
and ﬂavonoids with the ﬂavone backbone, are associated with a lower
risk of dementia [12,13].
Major soybean isoﬂavones, including glycitein (Gly) and genistein
(Gen) (Fig. 1) have been reported to inhibit Aβ-induced apoptosis of
cultured cells [14]. Several mechanisms may contribute to their neu-
roprotective effects: (i) isoﬂavones inhibit caspase activation, thereby
reducing apoptosis [14]; (ii) the antioxidant activity of isoﬂavones
mitigates Aβ-mediated toxicity, which is at least in part, mediated
by oxidative injury [14]; (iii) isoﬂavone-induced arginase 1 activity
protects glial cells and promotes axonal regeneration [15].
We previously reported that red wine-related ﬂavonoids with
the ﬂavone backbone are effective inhibitors of Aβ1–40 and Aβ1–42
ﬁbrillization in vitro, and that these compounds could also destabilize
preformed Aβ assemblies [8]. Our prior work demonstrated that a ﬂa-
vonoid myricetin, with a ﬂavone backbone (Supplemental Fig. S1C),
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Fig. 1. Structures of isoﬂavones analyzed in this study.
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monomeric Aβ, revealing a molecular mechanism for the ability of
ﬂavonoids to inhibit Aβ-ﬁbrillization and to destabilize preformed
fAβ [16]. Furthermore, ﬂavonoids with the ﬂavone backbone have
been shown to inhibit pre-protoﬁbrillar oligomerization with photo-
induced cross-linking of unmodiﬁed proteins (PICUP) [10].
Here,we examined the effects of isoﬂavones onAβ-ﬁbrillization, Aβ-
oligomerization and preformed Aβ assemblies, in vitro at pH 7.4 and
37 °C, using a nucleation-dependent polymerization model [17,18]
and PICUP followed by SDS-PAGE [10,19]. Moreover, we examined
whether isoﬂavones could interact with the monomers, oligomers and
ﬁbrils of Aβs by using three-dimensional ﬂuorescence spectroscopy.
2. Material and methods
2.1. Preparation of Aβ solutions
Aβ1–40 (triﬂuoroacetate form, lot number 541226; Peptide Insti-
tute Inc., Osaka, Japan), Aβ1–42 (triﬂuoroacetate form, lot number
580403, Peptide Institute Inc.), Aβ1–16 (HCl form, lot number
570408, Peptide Institute Inc.) and Aβ25–35 (triﬂuoroacetate form, lot
number 600102, Peptide Institute Inc.) were handled in a 4 °C cold
room. The peptides were dissolved by brief vortexing in 60 mM
NaOH–10 mM phosphate buffer (PB) and brought to ﬁnal concentra-
tions of 500 μM (2.2 mg/mL) and 250 μM, and stored at−80 °C before
assaying (fresh Aβ1–40, Aβ1–42, Aβ1–16 and Aβ25–35 solutions).
2.2. Peptide ﬁbrillization assay
Fibrillization of Aβ1–40 and Aβ1–42 was assayed as described [8].
The reaction mixture contained 25 μM Aβ1–40 or Aβ1–42, and 0, 25 or
250 μM of the isoﬂavone—Gen, daidzein (Dai), Gly, formononetin
(For), purunetin (Pur), or (±)-Equol (Equ) (Sigma Chemical Co.,
St. Louis, MO, USA) (Fig. 1)—and 10 mM PB (pH 7.4). The isoﬂavones
(Gen, Dai, Gly, For, Pur and Equ) were dissolved in 10 mM PB to a con-
centration at 2.5 mM, and these were added to the reactionmixture to
a ﬁnal concentration of 25 or 250 μM. Aliquots (100 μL) of the mixture
were transferred to 100 μL PCR tubes (Takara Shuzo Co. Ltd., Otsu,
Japan) and incubated at 37 °C for 0–7 days without agitation.
2.3. Fluorescence spectroscopy monitored by thioﬂavine T
Fluorescence spectroscopy was performed using Hitachi F-7000
ﬂuorescence spectrophotometers (Tokyo, Japan) as described [8].
Fluorescence measurements of fAβ1–40 and fAβ1–42 were obtained at
excitation and emission wavelengths of 445 and 490 nm, respectively,
with the reaction mixture containing 5 μM thioﬂavine T (ThT) (Wako
Pure Chemical Industries Ltd., Osaka, Japan) and 50 mM of glycine–NaOH buffer (pH 8.5). From each reaction tube, triplicate 5-μL aliquots
were removed and subjected to ﬂuorescence spectroscopy, and the
mean of the 3 measurements was determined by subtracting the ﬂuo-
rescence of a ThT blank. The concentration of isoﬂavones in the ThT
solution was diluted up to 1/200 of that in the reaction mixture. We
conﬁrmed that all our tested compounds did not quench ThT ﬂuores-
cence at the diluted concentration.
2.4. Chemical photo-induced cross-linking and determination of
oligomer frequency distributions
Immediately after their preparation, samples were cross-linked
using PICUP, as described [18]. Brieﬂy, to an 18-μL volume of protein so-
lution were added 1 μL of 1 mM tris(2,2-bipyridyl)
dichlororuthenium(II) (Ru(bpy)) and 1 μL of 20 mM ammonium
persulfate. The ﬁnal protein:Ru(bpy):ammonium persulfate molar ra-
tios for Aβ1–40 and Aβ1–42 were 0.29:1:20 and 0.16:1:20, respectively.
The mixture was irradiated for 1 s with visible light, and then the reac-
tion was quenched with 40 μL of Tricine sample buffer (Invitrogen,
Carlsbad, CA) containing 2 μL of 1 M dithiothreitol (DTT). Determina-
tion of the frequency distribution of the monomers and oligomers was
accomplished using SDS-PAGE and silver staining, as described [19].
Brieﬂy, 10 μL of each cross-linked sample was electrophoresed on a
10–20% gradient tricine gel and visualized by silver staining
(SilverXpress, Invitrogen). Non-cross-linked samples were used as con-
trols in each experiment.
2.5. Size exclusion chromatography
PICUP reagents were removed from cross-linked samples by size
exclusion chromatography as described [20]. To do so, 1.5-cm diame-
ter cylindrical columns were packed manually with 2 g of Bio-Gel P2
Fine (Bio-Rad), which produced a 6-mL column volume. The column
was ﬁrst washed twice with 25 mL of 50 mM NH4HCO3 (pH 8.5). A
216-μL volume of 50–100 μM cross-linked sample was then loaded.
The column was eluted with the same buffer at a ﬂow rate of approx-
imately 0.15 mL/min. The ﬁrst 1 mL of eluate was collected. The frac-
tionation range of the Bio-Gel P2 column is 100–1800 Da. Thus, Aβ
peptides eluted in the void volume, whereas Ru(bpy) (Mr=748.6),
ammonium persulfate (Mr=228.2) and dithiothreitol (Mr=154.2)
entered the column matrix and were separated from Aβ. Fractions
were lyophilized immediately after collection and were reconstituted
to the indicated concentration, in 10 mM PB (pH 7.4).
2.6. Cross-linked oligomer-destabilization assay
Destabilization of cross-linked Aβ oligomers was assessed as fol-
lows and then subjected to SDS-PAGE followed by silver staining.
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Aβ1–42, 250 μM of the isoﬂavone and 10 mM PB (pH 7.4) were placed
in PCR tubes. Each sample was incubated at 37 °C for 24 h, and dried
in a centrifugation evaporator for 12 h at 37 °C. Twenty microliters of
SDS sample buffer was added to these dried fractions, and 10 μL of
each sample was electrophoresed on a 10–20% gradient tricine gel
and visualized by silver staining (SilverXpress, Invitrogen).
2.7. Fibril-destabilization assay
Destabilization of fAβs was assessed as reported previously [8].
Brieﬂy, the reaction mixture contained 25 μM fresh fAβ1–40 or
fAβ1–42, 0–250 μM of the isoﬂavone and 10 mM PB (pH 7.4). Three
5-μL aliquots were subjected to ﬂuorescence spectroscopy and 30-μL
aliquots were placed in PCR tubes. The temperature was elevated
from 4 to 37 °C. Incubation times ranged from 0 to 24 h, as indicated
in each ﬁgure, and the reaction was stopped by placing the tubes on
ice. The mean of the 3 measurements was determined. At the diluted
concentration, these compounds did not compete with ThT for fAβ at
either 4 or 37 °C for a period of 1 min.
2.8. Fractionation of the reaction mixture and SDS-PAGE
Aβ1–40 and Aβ1–42 in the reaction mixtures of fAβ1–40 and fAβ1–42
destabilization were fractionated into phosphate buffer-soluble (PB-
sol) and PB-insoluble (PB-insol) fractions and then subjected to SDS-
PAGE followed by silver staining, as follows. Aliquots (20 μL) of the re-
action mixtures were removed and centrifuged at 21,500×g for 2 h at
4 °C. After removal of the supernatants containing Aβ1–40 and Aβ1–42
soluble in phosphate buffer (PB-sol fraction), the pellets were inde-
pendently dried in a centrifugation evaporator for 6 h at 37 °C. Then,
20 μL of 73% formic acid was added to the pellets containing Aβ1–40
and Aβ1–42 insoluble in PB (PB-insol fraction), vortex-mixed, incubat-
ed at room temperature for 1 h, and dried in a centrifugation evapora-
tor for 12 h at 25 °C. The PB-sol fraction was dried in a centrifugation
evaporator for 12 h at 25 °C. Twenty microliters of SDS sample buffer
was added to these dried fractions, and 6 μL of each sample was elec-
trophoresed on a 10–20% gradient tricine gel and visualized by silver
staining (SilverXpress, Invitrogen).
2.9. Electron microscopy (EM)
A 20-μL aliquot of each sample was spotted onto a carbon-coated
grid (Okenshoji, Co., Ltd., Tokyo, Japan) and incubated for 5 min. The
peptide was stained negatively with 1% phosphotungstic acid (pH
7.0). This solution was wicked off, and then the grid was air-dried.
Samples were examined using a JEM-1210 transmission electron mi-
croscope with an acceleration voltage of 75 kV.
2.10. Atomic force microscopy (AFM)
Peptide solutions were characterized using a Nanoscope IIIa
controller (Veeco Digital Instruments, Santa Barbara, CA) with a
multimode scanning probe microscope equipped with a JV (J-type
vertical) scanner. All measurements were carried out in the tapping
mode under ambient conditions using single-beam silicon cantileverFig. 2. Anti-ﬁbrillization effects of isoﬂavones on Aβ1–40 and Aβ1–42. (A–D) Effects of Gen (A
fresh Aβ1–40 and Aβ1–42, respectively, monitored by ThT ﬂuorescence. The reaction mixtures
0 (●), 25 (○) or 250 μM (□) of Gen (A, B) or Gly (C, D), were incubated at 37 °C for the indic
determined. Binding is expressed as a mean ﬂuorescence in arbitrary ﬂuorescence units±th
experiments. (E–T) Electron microscopy (E–L) and atomic force microscopy (M–T) of Aβ1–
(E–H, M–P) or Aβ1–42 (I–L, Q–T), 10 mM phosphate buffer (pH 7.4), and 0 (E, I, M, Q), 25 (F,
7 days (E–H, M–P) or 6 h (I–L, Q–T). Scale bars indicate 100 nm. (U, V) Effects of isoﬂavones
Aβ1–42, respectively, monitored by ThT ﬂuorescence. The reaction mixture, containing
isoﬂavones (gray columns), was incubated at 37 °C for 7 days (U) or 6 h (V), respectively. E
out compounds was regarded as 100%. Bars indicate SE. *pb0.05; post-hoc Tukey–Kramerprobes. A 10-μL aliquot of each lyophilized peptide, reconstituted to
a concentration of 25 μM in 10 mM PB (pH 7.4), was spotted onto
freshly cleaved mica (Okenshoji Co. Ltd., Tokyo, Japan), incubated at
room temperature for 5 min, rinsed with water, and then blown dry
with air. The sample was analyzed by examining at least ﬁve regions
of the mica surface to conﬁrm the homogeneity of the structures
throughout the sample.2.11. Three-dimensional ﬂuorescence spectroscopic characterization of
isoﬂavone emission spectra
Fluorescence emission of isoﬂavones in the presence or absence of
the various Aβ forms was characterized as follows. The reaction mix-
tures (200 μL), containing 0–50 μM isoﬂavones, 10 mM buffer and
0–50 μM Aβs were analyzed at 25 °C with a black microﬂuorimeter
cell (GL Sciences Inc., Tokyo, Japan). ΔFluorescence emission of Gly in
the presence of various Aβ species was obtained after subtraction of
both the ﬂuorescence emission of Gly alone and that of Aβs alone
from the actual ﬂuorescence emission of Gly mixed with Aβs. The
buffers used were citrate buffer at pH 4–6, phosphate buffer at pH
6–8, Tris–HCl buffer at pH 8–9 and glycine–NaOH buffer at pH 8.5–10.
Excitation and emission ﬂuorescence spectra were obtained immedi-
ately after the reaction mixture was made. Excitation and emission
were scanned in the range of 200–600 nmand 200–600 nm, respective-
ly. The scanning speed was 2400 nm/min, and excitation and emission
slits were set at 5 and 5 nm, respectively. Scans were completed in
5 min.2.12. Statistical analysis
One-way factorial analysis of variance followed by Tukey–Kramer
post‐hoc comparisons were used to determine statistical signiﬁcance
among data sets. Signiﬁcance was deﬁned as pb0.05.3. Results
3.1. Aβ ﬁbrillization assay and anti-ﬁbrillization effects of isoﬂavones on
Aβ1–40 and Aβ1–42
When fresh Aβ1–40 (Fig. 2A, C) or Aβ1–42 (Fig. 2B, D) was incubated
at 37 °C, the ﬂuorescence gently increased, ﬁnally reaching a plateau.
When Aβ1–40 was incubated with 25 or 250 μM Gen (Fig. 2A) or Gly
(Fig. 2C), the ﬁnal equilibrium level decreased in a dose-dependent
manner. Similar effects were observed for the two isoﬂavones with
Aβ1–42; Gen (Fig. 2B) and Gly (Fig. 2D). EM and AFM analyses revealed
that the number of thick straight ﬁbrils was reduced after incubating
fresh Aβ1–40 (Fig. 2F, N) or Aβ1–42 (Fig. 2J,R) with 25 μM Gly. Short ﬁ-
brils and amorphous aggregates were observed after incubating fresh
Aβ1–40 or Aβ1–42 with 250 μMGly (Fig. 2G,K,O,S) or Gen (Fig. 2H,L,P,T).
Thus, Gen and Gly can inhibit the ﬁbrillization of both Aβ1–40 and
Aβ1–42. We compared the anti-ﬁbrillization activities of the isoﬂavones
(Fig. 2U,V); statistical analysis revealed a signiﬁcant difference in the
potency of 250 μM Gen and Gly on both Aβ1–40 (Fig. 2U) and Aβ1–42
ﬁbrillization (Fig. 2V). Gly, at 250 μM, had the strongest activity., B) and Gly (C, D) on the kinetics of fAβ1–40 (A, C) and fAβ1–42 (B, D) formation from
, containing 25 μM Aβ1–40 (A, C) or Aβ1–42 (B, D), 10 mM phosphate buffer (pH 7.4), and
ated times. Periodically, three 5-μL aliquots were removed, and ThT binding levels were
e standard error (SE) (error bars). Each ﬁgure comprises data obtained in 3 independent
40 and Aβ1–42 assembly morphology. The reaction mixtures, containing 25 μM Aβ1–40
J, N, R) or 250 μMGly (G, K, O, S), or 250 μMGen (H, L, P, T) were incubated at 37 °C for
on the formation of Aβ1–40 ﬁbrils (fAβ1–40) (U) and fAβ1–42 (V) from fresh Aβ1–40 and
25 μM Aβ, 10 mM phosphate buffer (pH 7.4), and 25 (white columns) or 250 μM
ach column represents the average of 3 independent experiments. The average with-
tests.
R
el
a
tiv
e
 
flu
o
re
sc
e
n
ce
 (%
)
U
100
50
0
150
Fo
r
G
ly
Pu
r
D
ai
G
en
co
n
tro
l
Eq
u
R
el
a
tiv
e
 
flu
o
re
sc
e
n
ce
 (%
)
V
Eq
u
Fo
r
G
ly
Pu
r
D
ai
G
en
co
n
tro
l
100
50
0
150
*
**
*
M N O P
Q R S T
E F G Hcontrol
I J K L
A
Ar
bi
tra
ry
 
flu
o
re
sc
e
n
ce
Time (days)
0
100
C
Ar
bi
tra
ry
 
flu
o
re
sc
e
n
ce
0
Time (days)
100
B
Ar
bi
tra
ry
 
flu
or
es
ce
n
ce
D
Ar
bi
tra
ry
 
flu
o
re
sc
e
n
ce
Time (hr)
0
100
60 2 84
60 2 84
642
Time (hr)
0
100
0
0 642
1319M. Hirohata et al. / Biochimica et Biophysica Acta 1822 (2012) 1316–1324
A
M
r 
(kD
a)
M
r 
(kD
a)
Aβ1–40 B
3.5
6.0
14.4
21.5
31.0
36.5
97.4
66.3
55.4
Aβ1–42
3.5
6.0
14.4
21.5
31.0
36.5
97.4
66.3
55.4
1 2 3 4 5 6 7 8 9 10 11 12 13 14
cross-linking (–) (+) (+) (+) (+) (+) (+) (+) (+) (+) (+) (+) (+) (+)
1 2 3 4 5 6 7 8 9 10 11 12 13 14
25 μM
 Aβ
 1–42 alo
n
e
25 μM
 Aβ
 1–42 alo
n
e
+
 250 μM
 G
en
+
 25
 μM
 G
en
+
 250 μM
 G
ly
+
 25 μM
 G
ly
+
 250 μM
 D
ai
+
 25 μM
 D
ai
+
 25 μM
 For
+
 250 μM
 For
+
 25 μM
 Pur
+
 250 μM
 Pur
cross-linking (–) (+) (+) (+) (+) (+) (+) (+) (+) (+) (+) (+) (+) (+)
+
 250
 μM
 Equ
+
 250
 μM
 Equ
25 μM
 Aβ
 1–40
alo
n
e
25 μM
 Aβ
 1–40
alo
n
e
+
 250 μM
 G
en
+
 25 μM
 G
en
+
 250 μM
 G
ly
+
 25 μM
 G
ly
+
 250 μM
 D
ai
+
 25 μM
 D
ai
+
 25 μM
 For
+
 250 μM
 For
+
 25 μM
 Pur
+
 250 μM
 Pur
+
 250 μM
 Equ
+
 250 μM
 Equ
Fig. 3. Anti-oligomerization effects of isoﬂavones on Aβ1–40 and Aβ1–42. PICUP, followed by SDS-PAGE and silver staining, was used to determine the effects of isoﬂavones on Aβ1–40
(A) and Aβ1–42 oligomerization (B). Lanes 1, proteins alone (no cross-linking); lanes 2, proteins alone; lanes 3–14, proteins plus 25 or 250 μM isoﬂavones. Each gel is representative
of each of 3 independent experiments.
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isoﬂavones on Aβ1–40 and Aβ1–42
We examined the effects of isoﬂavones on Aβ oligomerization by
using PICUP, followed by SDS-PAGE and silver staining (Fig. 3). In
the absence of cross-linking by PICUP as a control, only Aβ1–40 mono-
mers (Fig. 3A, lane 1) and Aβ1–42 monomers and trimers (Fig. 3B, lane
1) were observed. The Aβ1–42 trimer band has been shown to be an
SDS-induced artifact [18]. After cross-linking, Aβ1–40 existed as a mix-
ture of monomers and oligomers of orders 2–4 (Fig. 3A, lane 2),
whereas Aβ1–42 comprised monomers and oligomers of orders 2–6
(Fig. 3B, lane 2). When 250 μM Gen or Gly was mixed with 25 μM
Aβ1–40, oligomerization was blocked signiﬁcantly with only dimer
bands visible (Fig. 3A, lanes 4 and 6). Mixing 25 μM Gen or Gly with
25 μM Aβ1–40, produced lower levels of inhibition (Fig. 3A, lanes 3
and 5). The effects of Dai, For, Pur and Equ on Aβ1–40 oligomerization
were weaker compared with Gen or Gly, with low tetramer band in-
tensities (Fig. 3A, lanes 7–14).
The effect of 250 μM Gen on Aβ1–42 oligomerization was equally
signiﬁcant with very low intensities of oligomer bands (Fig. 3B,
lanes 4 and 6). Mixing 25 μM Gen or Gly with 25 μM Aβ1–42 produced
weaker levels of inhibition (Fig. 3B, lanes 3 and 5). The effects of Dai,
For, Pur and Equ on Aβ1–42 oligomerization were weaker compared
with Gen or Gly (Fig. 3B, lanes 7–14).
These data show that Gen and Gly inhibit Aβ1–40 and Aβ1–42 oligo-
merization at compound:peptide ratios of 1:10.
3.3. Aβ assembly-destabilizing assay and ﬁbril-destabilizing effects of
isoﬂavones on Aβ1–40 and Aβ1–42
After incubating fresh fAβ1–40 and fAβ1–42 at 37 °C without
isoﬂavones as a control, ThT ﬂuorescence did not changeFig. 4. Aβ assembly-destabilizing assay and ﬁbril-destabilizing effects of isoﬂavones on Aβ1–
phosphate buffer (pH 7.4), and 25 (white columns) or 250 μM isoﬂavones (gray columns)
experiments. The average without compounds was regarded as 100%. Bars indicate SE. *pb
microscopy (K–R) analyses of Aβ1–40 and Aβ1–42 assembly morphology. The reaction mixtur
(pH 7.4), and 0 (C, G, K, O), 25 (D, H, L, P) or 250 μM Gly (E, I, M, Q), or 250 μM Gen (F, J, N,
100 nm. (S,T) Effects of Gly and Gen on fAβs-destabilization monitored by SDS-PAGE and s
reaction mixture containing 25 μM fAβ1–40 (S) or fAβ1–42 (T), 10 mM phosphate buffer (p
into PB-sol and PB-insol fractions. Each gel is representative of each of 3 independent exp
monitored by SDS-PAGE and silver staining. The reaction mixture containing 25 μM cross
fresh isoﬂavones was incubated at 37 °C for 24 h. Each gel is representative of each of 3 insigniﬁcantly (Fig. 4A, B). In contrast, when 250 μM Gly was incubat-
ed with 25 μM fAβ1–40, the ﬁnal equilibrium level signiﬁcantly de-
creased (Fig. 4A). Similar effects were observed when 250 μM Gen
or Gly was incubated with 25 μM fAβ1–42 (Fig. 4B). EM analyses rev-
ealed that the number of ﬁbrils was reduced slightly after incubat-
ing fAβ1–40 (Fig. 4D) or fAβ1–42 (Fig. 4H) with 25 μM Gly. Short
aggregates and amorphous aggregates were observed after incubat-
ing fAβ1–40 or fAβ1–42 with 250 μM Gly (Fig. 4E, I) or Gen (Fig. 4F, J).
AFM analyses revealed tangled and coated ﬁbrils with amorphous
aggregates after incubating fAβ1–40 or fAβ1–42 with Gly (Fig. 4L, M,
P, Q) or Gen (Fig. 4N, R).
Fig. 4S and T shows the effects of Gly and Gen on preformed
fAβ1–40 (Fig. 4S) or fAβ1–42 (Fig. 4T), determined by SDS-PAGE after
fractionation into PB-sol (supernatant) and PB-insol (pellet) frac-
tions. No proteins were detected in all of the PB-sol fractions. This im-
plies that although Gly and Gen could destabilize fAβ1–40 and fAβ1–42
to visible aggregates (Fig. 4A–R) they could not depolymerize fAβs to
PB-soluble Aβs including Aβ monomers.
Fig. 4U and V shows the effects of 250 μM isoﬂavones on 25 μM
cross-linked Aβ1–40 (Fig. 4U) or Aβ1–42 oligomers (Fig. 4V) deter-
mined by SDS-PAGE and silver staining. No isoﬂavone could change
the distributions of oligomer frequency.
3.4. Characterization of the ﬂuorescence emission of isoﬂavones in the
presence or absence of various Aβ species
Solution of 12.5 μMGly alone gave a maximum ﬂuorescence emis-
sion (565 arbitrary units (AU)) at 465 nm with excitation at 350 nm
(Supplemental Fig. S2; Gly, left). PB (control), Gen or Pur did not
show obvious peaks of ﬂuorescence emission (Supplemental Fig. S2;
left). We conﬁrmed that the peak ﬂuorescence of isoﬂavones did
not change for at least 5 min after the reaction mixture was made.40 and Aβ1–42. (A, B) The reaction mixture, containing 25 μM fAβ1–40 or fAβ1–42, 10 mM
was incubated at 37 °C for 24 h. Each column represents the average of 3 independent
0.05; post-hoc Tukey–Kramer tests. (C–R) Electron microscopic (C–J) and atomic force
es, containing 25 μM Aβ1–40 (C–F, K–N) or Aβ1–42 (G–J, O–R), 10 mM phosphate buffer
R) were incubated at 37 °C for 7 days (C–F, K–N) or 24 h (G–J, O–R). Scale bars indicate
ilver staining. Lane 1, 25 μM Aβ1–40 (S) or Aβ1–42 monomer (T) alone; lanes 2–7, the
H 7.4), and 0 or 250 μM fresh Gly or Gen was incubated at 37 °C for 24 h, fractionated
eriments. (U,V) Effects of isoﬂavones on the frequency of cross-linked Aβ oligomers
-linked Aβ1–40 (U) or Aβ1–42 (V), 10 mM phosphate buffer (pH 7.4), and 0 or 250 μM
dependent experiments.
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cence intensity (Supplemental Fig. S3). The ﬂuorescence change was
linear from 0 to 25 μM Gly (R2=0.976; Supplemental Fig. S3C),R
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and 12.5 μM Gly were monitored at the excitation and emission wavelengths of 350 and 465 nm, respectively. (D, E) ΔFluorescence spectra of Gly in the presence of Aβ1–42 mono-
mers. The reaction mixtures containing 0 or 12.5 μMAβ1–42 monomers, 10 mM buffer and 0 or 12.5 μMGly were monitored at an emission of 465 nm (D) or an excitation of 350 nm
(E). The buffers used were citrate buffer at pH 4–6, phosphate buffer at pH 6–8, Tris–HCl buffer at pH 8–9 and glycine–NaOH buffer at pH 8.5–10. (F) Effects of pH on the
Δﬂuorescence emission of Gly in the presence of Aβ1–42 monomers. The reaction mixtures containing 12.5 μM Aβ1–42 monomers, 10 mM phosphate buffer (pH 4–10), and 0 or
12.5 μM Gly were monitored at the excitation and emission wavelengths of 350 and 465 nm, respectively.
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used monomers, oligomers and ﬁbrils of Aβ1–40 or Aβ1–42. Fluores-
cence emission of 12.5 μM Aβ1–42 monomers or oligomers alone,
obtained at the excitation and emission wavelengths of 350 and
465 nm, respectively, was neglectable (Supplemental Fig. S2 and S4).
Solution of 12.5 μMAβ1–42 ﬁbrils gave a maximum ﬂuorescence emis-
sion of 410 nm with excitation at 300 nm (Supplemental Fig. S2),
however, they gave little ﬂuorescence emission at 465 nm with exci-
tation at 350 nm (Supplemental Fig. S2 and S4). After mixing with
Aβ1–42 monomers, oligomers or ﬁbrils, 12.5 μM Gly solution emitted
a signiﬁcantly higher ﬂuorescence at 465 nm with an excitation max-
imum at 350 nm (pb0.05; Supplemental Fig. S2; Gly). Fig. 5 show the
Δﬂuorescence excitation (Fig. 5A) and emission spectra (Fig. 5B) of
Gly in the presence of individual Aβ species after subtracting each
ﬂuorescence of Gly and Aβ alone. The maxima of Δﬂuorescence emis-
sion were also observed at the excitation and emission wavelengths
of 350 (Fig. 5A) and 465 nm (Fig. 5B), respectively. The higher concen-
tration of Aβ1–42 species was associated with a higher ﬂuorescence in-
tensity (Fig. 5C). The Δﬂuorescence of Gly in the presence of Aβ1–42
monomer was pH-dependent, exhibiting a maximum around pH 10
and a minimum around pH 4–6 (Fig. 5D–F). These data indicates
that theΔﬂuorescence obtained at an emission of 465 nmwith excita-
tion at 350 nm reﬂects the binding of Gly to Aβmonomers, oligomers
and ﬁbrils at pH 7.4.After mixing Aβ1–40 species with Gly, the Δﬂuorescence spectra
were nearly identical to those of Aβ1–42 species, and slightly lower
ﬂuorescence levels were observed compared to mixing Aβ1–42 species
with Gly (Fig. 5A,B). These data are indicating that Gly could interact
with monomers, oligomers and ﬁbrils of Aβ1–40 and Aβ1–42 in sample
solution. In contrast, minimal changes in the ﬂuorescence spectra
were observed when Aβ1–42 were mixed with PB (control), Gen, Dai,
For, Pur or Equ (Supplemental Fig. S2).
3.5. The Δﬂuorescence emission of glycitein in the presence of Aβ
fragments
To determine which regions of monomeric Aβs Gly interacts with,
we used different Aβ fragments. Fig. 6 shows the Δﬂuorescence en-
hancement of Gly in the presence of Aβ fragments. The spectra of
Gly mixed with Aβ1–40 or Aβ1–16 were nearly identical to that with
Aβ1–42. In comparison, a much larger Δﬂuorescence was observed
after mixing Gly with Aβ25–35 (pb0.05). Gly interacted with different
Aβ fragments (Aβ1–42, Aβ1–40, Aβ1–16 and Aβ25–35), exhibiting the
highest Δﬂuorescence enhancement with Aβ25–35. Fig. 6C shows that
the Δﬂuorescence intensity rose with increasing concentration of Aβ
fragments. The Δﬂuorescence of Gly ultimately reached plateau levels
at a compound:peptide ratio of 5:2 for Aβ1–42, Aβ1–40 and Aβ1–16, and
at a ratio of 1:1 or more for Aβ25–35. These results suggest that Gly can
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Aβ1–16 and Aβ25–35, and that Gly may have the most potent afﬁnity
for Aβ25–35 among the Aβ fragments examined in this study.
4. Discussion
We demonstrate that isoﬂavones, especially Gly and Gen, can in-
hibit the ﬁbrillization as well as the oligomerization in a dose-
dependent manner. Also, these compounds destabilized preformed
fAβ1–40 and fAβ1–42. In addition, our three-dimensional ﬂuorescence
spectroscopic analyses showed that Gly directly interacted with
monomers, oligomers and ﬁbrils of Aβ1–40 and Aβ1–42 at pH 7.4, indi-
cating the binding of Gly to these Aβ species. Moreover, Gly interacted
with different Aβ fragments (Aβ1–42, Aβ1–40, Aβ1–16 and Aβ25–35),
exhibiting the most potent afﬁnity for Aβ25–35. Gly can interact with
the limited number of binding sites along the length of monomeric
Aβs.
These interactions of Gly with Aβs would explain the anti-
ﬁbrillation and anti-oligomerization effects of Gly on Aβ1–40 and
Aβ1–42. Gly initially binds with the site(s) present in monomeric Aβs,
thereby preventing ﬁbrillation and oligomerization. Alternatively,
Gly binds to Aβ ﬁbrils or oligomers, thus inhibiting the addition of
Aβ monomers onto the growing ends of Aβ assembly. Previously, we
demonstrated that a ﬂavonoid myricetin bound to fAβs by using
three-dimensional ﬂuorescence spectroscopy and surface plasmon
resonance analyses [16]. Prior work using circular dichroism (CD)
spectroscopy and PICUP showed that a ﬂavonoid could inhibit transi-
tions of initial coil‐α-helix/β-sheet secondary structure and subse-
quent pre-protoﬁbrillar oligomerization [10].
The binding of Gly to fAβs would achieve the ﬁbril-destabilizing ef-
fects of Gly on preformed fAβ1–40 and fAβ1–42. The ﬂuorescence
changes of fAβ1–42 by Gly were slightly greater than those of fAβ1–40,
and, probably related to it, the ﬁbril-destabilizing activities of Gly on
fAβ1–42 were slightly stronger than those on fAβ1–40; this may be re-
lated to structural differences between fAβ1–40 and fAβ1–42. AFM anal-
yses revealed fAβs coated and tangled into amorphous aggregates
after the fAβ-destabilizing assay with Gly. By SDS-PAGE analyses
after fractionation into PB-sol and PB-insol, Gly seems not to depoly-
merize fAβs to PB-soluble Aβs including Aβmonomers.
Although the ﬂuorescence changes suggested the binding of Gly to
Aβ oligomers, Gly could not destabilize preformed Aβ oligomers
assembled by PICUP. There has been no report of compounds which
destabilize preformed Aβ oligomers assembled by PICUP.Among prior works on isoﬂavones, Gen has been reported to bind
serum albumin noncovalently and exhibit enhanced ﬂuorescence
emission [21]; Gly, Gen and Dai have also been reported to bind the
monomeric form of transthyretin protein (TTR) [22]. Because Gen
did not show obvious peaks of ﬂuorescence emission, our three-
dimensional ﬂuorescence spectroscopic methods were not available
to analyze any interaction between Gen and Aβs, nor to explain the
mechanism of Gen's anti-ﬁbrillation, anti-oligomerization and ﬁbril-
destabilizing effects on Aβs.
Understanding of the relationship between the chemical structure
of the ﬂavonoids and these speciﬁc anti-amyloid effects may lead to
development of more effective drug designs with more potent anti-
amyloid effects, requiring further studies.
The anti-ﬁbrillization, anti-oligomerization and ﬁbril-destabilizing
effects of isoﬂavones require concentrations of at least 250 μM in our
in vitro system. Generally, under habitual dietary conditions, plasma
Gly levels are in the range of 0.004–1.2 μM [23–25]. Six hours after in-
take of soymilk and tofu, 1.7 μM and 1.3 μM of Gen were measured in
plasma, respectively [26]. Isoﬂavone concentrations of 0.5–0.9 μM
were measured in the blood of 3 adults after consuming soy nutri-
tional supplements [25]. Seven infants eating soy-based formula had
2–7 μM concentrations of isoﬂavones in their blood [25]. Although it
was reported that the penetration of ﬂavonoids into the central ner-
vous system depends on their lipophilicity [27], there is little infor-
mation about the interaction of isoﬂavones with the blood–brain
barrier. In any case, it is unlikely that the estimated isoﬂavone con-
centrations in the cerebrospinal ﬂuid (CSF) would be higher than
10 μM under habitual dietary conditions, and these would be lower
than those used in this study. However, low concentrations of
isoﬂavones may exhibit anti-amyloidogenic activities in vivo when
administered for a long period. Alternatively, supplemental intake of
isoﬂavones could sufﬁciently increase CSF concentrations to provide
anti-amyloidogenic effects. There have been no clinical trials on the
neurological effects of isoﬂavone consumption. The central nervous
system levels of isoﬂavones have never reported in the studies using
animal model fed with isoﬂavones. Previous reports demonstrated
that long-term orally administered different polyphenolic ﬂavonoids,
including (+)-catechin and (−)-epicatechin, signiﬁcantly attenuated
cognitive deterioration and improved cognitive function in a mouse
model of AD with reduced oligomeric Aβ in the brain [28,29]; the cal-
culated total metabolite level in the brain was at the very most 1.1 pM
after treatment with orally 200 mg/kg/day of the polyphenolic ﬂavo-
noids, equivalent to a human dosage of 1 g/day [29].
1324 M. Hirohata et al. / Biochimica et Biophysica Acta 1822 (2012) 1316–1324Recent laboratory ﬁndings indicate that isoﬂavones may protect
against dementia. Gen was protective against oxidative injury caused
by Aβ25–35 treatment, and it helped tomaintain redox balance in PC12
cells [30]. Gen could also rescue neurons from Aβ-induced cell death
by inhibiting the activation of p38 MAP kinase [31]. Furthermore,
Gen can inhibit Aβ–associated inﬂammation—this appeared to be
due to its ability to induce PPAR-γ expression in cultured astrocytes
[32]. Mixed soy isoﬂavones, which contain Gen, Dai and Gly, attenuate
oxidative stress and improve parameters related to aging and
Alzheimer's disease in C57BL/6J mice treated with D-galactose [33].
In transgenic Caenorhabditis elegans, Gly may protect against Aβ-
induced toxicity through its combined ability to mitigate oxidative in-
jury and inhibit Aβ deposition [34]. Finally, this study demonstrates
that isoﬂavones, especially Gly and Gen, can inhibit Aβ assembly,
and that Gly's effects may be mediated by direct binding to Aβmono-
mers, oligomers and ﬁbrils. Our results indicate that compounds with
an isoﬂavone backbone may also be promising candidates for applica-
tion in therapeutic strategies targeting Aβ assemblies.
In conclusion, we show that isoﬂavones, especially Gly and Gen,
have anti-ﬁbrillization, anti-oligomerization and ﬁbril-destabilizing
effects on Aβ1–40 and Aβ1–42 in vitro. In particular, Gly exerted an
anti-amyloidogenic effect by binding to Aβ monomers, oligomers
and ﬁbrils. Gly interacted with the limited number of binding sites
along the length of monomeric Aβ, and with different Aβ fragments
(Aβ1–42, Aβ1–40, Aβ1–16 and Aβ25–35) exhibiting the most potent afﬁn-
ity for Aβ25–35. Isoﬂavonesmay hold promise as a treatment option for
preventative strategies targeting amyloid formation in Alzheimer's
disease.
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